Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, 15875/4413, Iran.
Stem Cell and Regenerative Medicine Group, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, 14965/161, Iran.
Sci Rep. 2022 May 21;12(1):8595. doi: 10.1038/s41598-022-12332-z.
A combination of [Formula: see text] nanotube array (TON) and controlled drug release system is employed to provide enhanced surface properties of titanium implants. Electrochemical anodization process is used to generate TON for introducing, vancomycin, an effective antibacterial drug against Staphylococcus aureus. TON loaded vancomycin is then coated with a number of layers of 10% gelatin using spin coating technique. The gelatin film is reinforced with graphene oxide (GO) nanoparticles to improve the surface bioactivity. The surface of the samples is characterized by field emission electron microscopy (FESEM), energy-dispersive X-ray spectroscopy (EDS), and contact angle measurement. The results illustrate that the TON was constructed and vancomycin molecules are successfully loaded. The drug release study shows that the amount of released vancomycin is controlled by the thickness of gelatin layers. With an increase in gelatin film layers from 3 to 7, the release of vancomycin in the burst release phase decreased from 58 to 31%, and sustained release extended from 10 to 17 days. The addition of GO nanoparticles seems to reduce drug release in from 31 to 22% (burst release phase) and prolonged drug release (from 17 to 19 days). MTT assay indicates that samples show no cytotoxicity, and combination of GO nanoparticles with gelatin coating could highly promote MG63 cell proliferation. Soaking the samples in SBF solution after 3 and 7 days demonstrates that hydroxy apatite crystals were deposited on the TON surface with GO-gelatin coating more than surface of TON with gelatin. Moreover, based on the results of disc diffusion assay, both samples (loaded with Vancomycin and coated with gelatin and gelatin-GO) with the inhibition zones equaled to 20 mm show effective antibacterial properties against S. aureus. The evidence demonstrates that titania nanotube loaded with vancomycin and coated with gelatin-GO has a great potential for general applicability to the orthopedic implant field.
采用[公式:见文本]纳米管阵列(TON)和控释药物系统相结合,为钛植入物提供增强的表面性能。采用电化学阳极氧化工艺生成 TON,以引入万古霉素,这是一种针对金黄色葡萄球菌的有效抗菌药物。然后,使用旋涂技术在 TON 上涂覆多层 10%明胶。使用氧化石墨烯(GO)纳米粒子增强明胶膜的表面生物活性。通过场发射电子显微镜(FESEM)、能谱(EDS)和接触角测量对样品表面进行表征。结果表明,构建了 TON,并成功负载了万古霉素分子。药物释放研究表明,明胶层的厚度控制着万古霉素的释放量。随着明胶膜层数从 3 层增加到 7 层,在突释阶段释放的万古霉素量从 58%减少到 31%,持续释放时间从 10 天延长到 17 天。GO 纳米粒子的添加似乎减少了 31%到 22%(突释阶段)的药物释放,并延长了药物释放(从 17 天到 19 天)。MTT 试验表明,样品无细胞毒性,GO 纳米粒子与明胶涂层的结合可高度促进 MG63 细胞增殖。将样品浸泡在 SBF 溶液中 3 天和 7 天后,证明羟基磷灰石晶体沉积在 TON 表面上的 GO-明胶涂层上多于 TON 表面上的明胶涂层。此外,根据圆盘扩散试验的结果,两种样品(载有万古霉素并用明胶和明胶-GO 涂层)的抑菌圈直径均达到 20mm,对金黄色葡萄球菌表现出有效的抗菌性能。证据表明,载有万古霉素的二氧化钛纳米管并用明胶-GO 涂层具有广泛应用于骨科植入物领域的巨大潜力。